SEC EDGAR · Nov 3, 08:21 PM UTC
Twist Bioscience officer Patrick Finn files Form 144 for 2,565 shares tied to vesting
Historical operation · Retained
“Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.”
Quoted source · 12 source segments
- [1] primary_doc.xml
- [2] primary_doc.xml
- [3] primary_doc.xml
- [4] primary_doc.xml
- [5] primary_doc.xml
- [6] primary_doc.xml
- [7] primary_doc.xml
- [8] primary_doc.xml
- [9] primary_doc.xml
- [10] primary_doc.xml
- [11] primary_doc.xml
- [12] primary_doc.xml
Model assessment
Form 144 shows officer Patrick Finn proposing to sell 2,565 common shares acquired via restricted stock vesting on 11/02/2026, with the filing noting the sale covers a tax obligation from a vested equity award distribution. Prior sales in the past three months are also disclosed. This is a routine insider equity-award disposition, not a material catalyst or impairment of Twist Bioscience's expected fundamentals, and no fresh prior system signal exists to preserve, so the evidence is non-actionable.
12 exact filing citations